Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Nimer

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Journal of Toxicology and Environmental Health. Part A|November 22, 2000
Review of the Cox hematotoxicity modelM L Heaney, S D Nimer
Blood|December 1, 1987
The 5q- abnormalityS D Nimer, D W Golde
The New England Journal of Medicine|September 14, 1995
Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphomaS D Nimer, A Zelenetz, C Portlock
Cytokine|November 5, 1999
GM-CSF rescues TF-1 cells from growth factor withdrawal-induced, but not differentiation-induced apoptosis: the role of BCL-2 and MCL-1L Klampfer, J Zhang, S D Nimer
Bone Marrow Transplantation|August 1, 1993
Use of recombinant GM-CSF following allogeneic BMTs for aplastic anemiaL Chap, G Schiller, S D Nimer
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1997
AML1A and AML1B can transactivate the human IL-3 promoterH Uchida, J Zhang, S D Nimer
Annals of Internal Medicine|March 1, 1991
Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effectsA R Nissenson, S D Nimer, D L Wolcott
Blood|August 1, 1994
An increased HLA DR2 frequency is seen in aplastic anemia patientsS D Nimer, P Ireland, A Meshkinpour, et al.
JAMA|December 9, 1988
Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factorS D Nimer, R E Champlin, D W Golde
The Year in Immunology|January 1, 1988
The expression and target cell specificity of human granulocyte-macrophage colony-stimulating factorS D Nimer, J C Gasson, J F DiPersio
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Journal of Toxicology and Environmental Health. Part A|November 22, 2000
Review of the Cox hematotoxicity modelM L Heaney, S D Nimer
Blood|December 1, 1987
The 5q- abnormalityS D Nimer, D W Golde
The New England Journal of Medicine|September 14, 1995
Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphomaS D Nimer, A Zelenetz, C Portlock
Cytokine|November 5, 1999
GM-CSF rescues TF-1 cells from growth factor withdrawal-induced, but not differentiation-induced apoptosis: the role of BCL-2 and MCL-1L Klampfer, J Zhang, S D Nimer
Bone Marrow Transplantation|August 1, 1993
Use of recombinant GM-CSF following allogeneic BMTs for aplastic anemiaL Chap, G Schiller, S D Nimer
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1997
AML1A and AML1B can transactivate the human IL-3 promoterH Uchida, J Zhang, S D Nimer
Annals of Internal Medicine|March 1, 1991
Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effectsA R Nissenson, S D Nimer, D L Wolcott
Blood|August 1, 1994
An increased HLA DR2 frequency is seen in aplastic anemia patientsS D Nimer, P Ireland, A Meshkinpour, et al.
JAMA|December 9, 1988
Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factorS D Nimer, R E Champlin, D W Golde
The Year in Immunology|January 1, 1988
The expression and target cell specificity of human granulocyte-macrophage colony-stimulating factorS D Nimer, J C Gasson, J F DiPersio
Pageof 9